CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 120 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $871,000 | -6.5% | 72,200 | -2.8% | 0.01% | -23.1% |
Q4 2018 | $932,000 | +144.6% | 74,300 | +189.1% | 0.01% | +225.0% |
Q3 2018 | $381,000 | -8.4% | 25,700 | +4.0% | 0.00% | -20.0% |
Q2 2018 | $416,000 | +99.0% | 24,700 | +64.7% | 0.01% | +66.7% |
Q2 2017 | $209,000 | -76.1% | 15,000 | -70.8% | 0.00% | -72.7% |
Q1 2017 | $875,000 | +375.5% | 51,300 | +186.6% | 0.01% | +266.7% |
Q4 2016 | $184,000 | +7.6% | 17,900 | +5.9% | 0.00% | +50.0% |
Q3 2016 | $171,000 | – | 16,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |